EP3370765A4 - Nouvelle plateforme de vaccins à adn - Google Patents

Nouvelle plateforme de vaccins à adn Download PDF

Info

Publication number: EP3370765A4
Authority: EP; European Patent Office
Prior art keywords: dna vaccine; novel platform; platform dna; novel; vaccine
Prior art date: 2015-11-06
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP16863078.8A

Other languages

German (de)

English (en)

Other versions

EP3370765A1 (fr

Inventor

Victor G. SOLODUSHKO

Brian Fouty

Vira BITKO

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

University of South Alabama

Original Assignee

University of South Alabama

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2015-11-06

Filing date

2016-11-04

Publication date

2019-06-12

2016-11-04 Application filed by University of South Alabama filed Critical University of South Alabama

2016-11-04 Priority claimed from PCT/US2016/060631 external-priority patent/WO2017079625A1/fr

2018-09-12 Publication of EP3370765A1 publication Critical patent/EP3370765A1/fr

2019-06-12 Publication of EP3370765A4 publication Critical patent/EP3370765A4/fr

Status Withdrawn legal-status Critical Current

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/002—Protozoa antigens
- A61K39/015—Hemosporidia antigens, e.g. Plasmodium antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
- A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6075—Viral proteins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
- C12N2760/18534—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Tropical Medicine & Parasitology (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Immunology (AREA)
Microbiology (AREA)
Mycology (AREA)
Epidemiology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

EP16863078.8A 2015-11-06 2016-11-04 Nouvelle plateforme de vaccins à adn Withdrawn EP3370765A4 (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US201562285732P	2015-11-06	2015-11-06
PCT/US2016/060631 WO2017079625A1 (fr)	2015-11-06	2016-11-04	Nouvelle plateforme de vaccins à adn

Publications (2)

Publication Number	Publication Date
EP3370765A1 EP3370765A1 (fr)	2018-09-12
EP3370765A4 true EP3370765A4 (fr)	2019-06-12

Family

ID=63077614

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP16863078.8A Withdrawn EP3370765A4 (fr)	2015-11-06	2016-11-04	Nouvelle plateforme de vaccins à adn

Country Status (1)

Country	Link
EP (1)	EP3370765A4 (fr)

2016
- 2016-11-04 EP EP16863078.8A patent/EP3370765A4/fr not_active Withdrawn

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
WU H ET AL: "RSV fusion (F) protein DNA vaccine provides partial protection against viral infection", VIRUS RESEARCH, AMSTERDAM, NL, vol. 145, no. 1, 1 October 2009 (2009-10-01), pages 39 - 47, XP026564433, ISSN: 0168-1702, [retrieved on 20090621], DOI: 10.1016/J.VIRUSRES.2009.06.012 *

Also Published As

Publication number	Publication date
EP3370765A1 (fr)	2018-09-12

Legal Events

Date	Code	Title	Description
2017-05-13	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE
2018-08-10	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2018-08-10	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE
2018-09-12	17P	Request for examination filed	Effective date: 20180503
2018-09-12	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
2018-09-12	AX	Request for extension of the european patent	Extension state: BA ME
2019-02-13	DAV	Request for validation of the european patent (deleted)
2019-02-13	DAX	Request for extension of the european patent (deleted)
2019-06-12	A4	Supplementary search report drawn up and despatched	Effective date: 20190513
2019-06-12	RIC1	Information provided on ipc code assigned before grant	Ipc: A61K 39/12 20060101AFI20190507BHEP Ipc: A61K 39/145 20060101ALI20190507BHEP Ipc: A61P 33/00 20060101ALI20190507BHEP Ipc: C12N 7/01 20060101ALI20190507BHEP
2020-04-01	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: EXAMINATION IS IN PROGRESS
2020-05-06	17Q	First examination report despatched	Effective date: 20200406
2023-07-12	P01	Opt-out of the competence of the unified patent court (upc) registered	Effective date: 20230530
2023-11-17	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
2023-12-20	18D	Application deemed to be withdrawn	Effective date: 20230721

Publication	Publication Date	Title
EP3134131A4 (fr)	2018-06-13	Vaccins à base d'acide nucléique
EP3322441A4 (fr)	2018-12-19	Compositions de vaccin
EP3102190A4 (fr)	2017-09-06	Nouvelles formulations pharmaceutiques
EP3102722A4 (fr)	2017-10-04	Fractionnement du génome
EP3193888A4 (fr)	2018-03-14	Nouvelles formulations
GB201518684D0 (en)	2015-12-02	Vaccine
EP3181982A4 (fr)	2018-04-18	Plate-forme à cardan
EP3259032A4 (fr)	2018-10-10	Descendeur amélioré
EP3373928A4 (fr)	2019-08-07	Nouvelles formulations
IL266237A (en)	2019-06-30	Tolerogenic DNA composition
GB201522132D0 (en)	2016-01-27	Vaccine
GB201517241D0 (en)	2015-11-11	DNA modification
HK1235003A1 (zh)	2018-03-02	核酸疫苗
AU2016902014A0 (en)	2016-06-09	Vaccine
HK1259943A1 (zh)	2019-12-06	人类巨细胞病毒疫苗
AU2015903721A0 (en)	2015-09-24	Selection platform
HK1234652A1 (en)	2018-02-23	Protein formulations
GB201518917D0 (en)	2015-12-09	Vaccination
EM27178760001S (fr)	2015-09-07	Plates-formes
HK1227731A1 (en)	2017-10-27	Novel pharmaceutical formulations
GB201503266D0 (en)	2015-04-15	Vaccination
AU2015901481A0 (en)	2015-05-14	Schistosoma vaccine
HK1236563A1 (en)	2018-03-29	Gene expression system
AU2014904999A0 (en)	2015-01-15	Working platform
AU2014901271A0 (en)	2014-04-17	UPPER c